English  |  正體中文  |  简体中文  |  Items with full text/Total items : 54371/62179 (87%)
Visitors : 9058593      Online Users : 84
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTHU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    National Tsing Hua University Institutional Repository > 生命科學院  > 分子與細胞生物研究所 > 博碩士論文  >  以酵素工程法開發黏質沙雷氏菌BCRC10948之新型具有高催化效率短鏈脫氫?還原?

    Please use this identifier to cite or link to this item: http://nthur.lib.nthu.edu.tw/dspace/handle/987654321/86879

    Title: 以酵素工程法開發黏質沙雷氏菌BCRC10948之新型具有高催化效率短鏈脫氫?還原?
    Authors: 鄒宇
    Tsou, Yu
    Description: GH02102080535
    Date: 2015
    Keywords: 苯腎上腺素 短鏈脫氫?/還原? 酵素工程 生物催化法 黏質沙雷氏菌
    Phenylephrine Short-chain dehydrogenase/reductase Enzyme engineering Biocatalysis Serratia marcescens
    Abstract: (R)-Phenylephrine [(R)-PE] 是一種α1腎上腺素受體興奮劑,相較於其他類腎上腺素藥物其副作用較低,目前被廣泛用於舒緩鼻充血和延長麻醉時效。利用化學合成方式生產(R)-PE時,非藥用(S)-PE幾乎占整體產量的一半,且生產過程需用到觸媒並在高溫高壓下進行,不僅成本高且對環境不友善。近期中興大學許文輝教授及楊明德教授實驗室從Serratia marcescens BCRC 109485中分離出一株具有可以將1-(3-hydroxyphenyl)-2-(methylamino) ethanone (HPMAE) 轉換成(R)-PE的short-chain dehydrogenase/reductase (SDR),稱之為SmSDR。從SmSDR的轉換結果中發現鏡像異構物選擇性[(R)-PE)]高達99%,但整體產率及轉換率不佳,無法達到工業化應用的標準。此篇研究即是與中興大學合作,希望利用晶體繞射學技術解出SmSDR的蛋白質結構,之後再更進一步分析其結構特性、催化機制以及反應物專一性,並依據這些資訊來設計定點突變,即是利用蛋白質工程的方式改良SmSDR的催化效率使之有潛力應用在藥物生產工業上。首先我們成功的培養出SmSDR晶體並解出具有1.47A高解析度的蛋白質結構,接著用電腦模擬的方式建立出蛋白質與反應物的作用關係,依據這些資訊來設計突變點,最後得到具有不改變鏡像選擇性且酵素活性提高的雙點突變株SmSDR-F98YF202L,且在生物轉化過程中提高了(R)-PE)的轉換率,證明了有效的突變位點的確可以使SmSDR的催化效力增加,而我們的最終目標為將SmSDR之產率及轉換率改良到足以應用在工業化生產製程上。
    (R)-Phenylephrine [(R)-PE] is an α1-adrenergic receptor agonist widely used as a nasal decongestant and a cardiac agent without major side effects opposing to other adrenergic drugs such as ephedrine. In addition, the current mass-production procedure usually consists of (S) chiral form (50%). In an end to increase the specificity, a bio-catalytic transformation procedure using a novel short-chain dehydrogenase/reductase (SDR) from Serratia marcescens BCRC 10948 (Peng, G. J. et al.) to convert 1-(3-hydroxyphenyl)-2-(methylamino) ethanone (HPMAE) into an enantioseletive (R)-PE (more than 99%) has been attempted. However, this method performs relatively low conversion yield and productivity. In this study, we aim to determine the crystallographic structure of SmSDR as a structural basis to engineer high-activity SmSDR variants. Here, we report the 1.47 A atomic-resolution apo-form structure. A liganded complex was built using Discovery Studio. Several mutants were predicted and characterized based on a structure-guided approach. A double mutant SmSDR-F98YF202L was found to display the highest activity. Furthermore, this mutant demonstrated a much higher conversion yield and productivity in the whole-cell assay, suggesting a valuable engineered variant for pharmaceutical applications.
    URI: http://nthur.lib.nthu.edu.tw/dspace/handle/987654321/86879
    Source: http://thesis.nthu.edu.tw/cgi-bin/gs/hugsweb.cgi?o=dnthucdr&i=sGH02102080535.id
    Appears in Collections:[分子與細胞生物研究所] 博碩士論文

    Files in This Item:

    File SizeFormat
    GH02102080535.pdf294KbAdobe PDF212View/Open


    SFX Query


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback